P

Inventor

NISHIMURA NOBUKO

US45 patents
⚠️ This page may combine multiple inventors who share the name “NISHIMURA NOBUKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

35 patents
US10519146B2Dec 31, 2019

KRAS G12C inhibitors and methods of using the same

AMGEN INC81 citations97
US6878714B2Apr 12, 2005

Substituted alkylamine derivatives and methods of use

AMGEN INC85 citations97
US11090304B2Aug 17, 2021

KRAS G12C inhibitors and methods of using the same

AMGEN INC33 citations94
US9611261B2Apr 4, 2017

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC25 citations94
US9085576B2Jul 21, 2015

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC31 citations94
US10221162B2Mar 5, 2019

Triazole agonists of the APJ receptor

AMGEN INC12 citations92
US9868721B2Jan 16, 2018

Triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9845310B2Dec 19, 2017

Intermediates for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9751864B2Sep 5, 2017

Methods for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9745286B2Aug 29, 2017

Triazole agonists of the APJ receptor

AMGEN INC16 citations92
US9656997B2May 23, 2017

Triazole agonists of the APJ receptor

AMGEN INC16 citations92
US9656998B2May 23, 2017

Intermediates for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9573936B2Feb 21, 2017

Triazole agonists of the APJ receptor

AMGEN INC19 citations92
US7102009B2Sep 5, 2006

Substituted amine derivatives and methods of use

AMGEN INC49 citations92
US12083121B2Sep 10, 2024

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC7 citations85
US11905281B2Feb 20, 2024

KRAS G12C inhibitors and methods of using the same

AMGEN INC13 citations85
US11766436B2Sep 26, 2023

KRAS G12C inhibitors and methods of using the same

AMGEN INC11 citations85
US11285156B2Mar 29, 2022

Substituted piperazines as KRAS G12C inhibitors

AMGEN INC16 citations85
US10150760B2Dec 11, 2018

Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor

AMGEN INC8 citations84
US9988369B2Jun 5, 2018

Heterocyclic triazole compounds as agonists of the APJ receptor

AMGEN INC8 citations83
US7320992B2Jan 22, 2008

Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use

AMGEN INC15 citations83
US7101868B2Sep 5, 2006

Substituted arylamine derivatives and methods of use

AMGEN INC20 citations83
US8772480B2Jul 8, 2014

Inhibitors of PI3 kinase and/or mTOR

AMGEN INC5 citations71
US12440491B2Oct 14, 2025

KRAS G12C inhibitors and methods of using the same

AMGEN INC1 citations64
US12441736B2Oct 14, 2025

KIF18A inhibitors

AMGEN INC1 citations63
US11046680B1Jun 29, 2021

Heteroaryl-substituted triazoles as APJ receptor agonists

AMGEN INC2 citations62
US10906890B2Feb 2, 2021

Triazole phenyl compounds as agonists of the APJ receptor

AMGEN INC1 citations62
US12459932B2Nov 4, 2025

KIF18A inhibitors

AMGEN INC1 citations61
US11020395B2Jun 1, 2021

Cycloalkyl substituted triazole compounds as agonists of the APJ receptor

AMGEN INC1 citations61
US11191762B2Dec 7, 2021

Alkyl substituted triazole compounds as agonists of the APJ Receptor

AMGEN INC0 citations51
US9550762B2Jan 24, 2017

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

AMGEN INC1 citations51
US7662811B2Feb 16, 2010

1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use

AMGEN INC1 citations51
US12540129B2Feb 3, 2026

KIF18A inhibitors

AMGEN INC0 citations50
US12435058B2Oct 7, 2025

KIF18A inhibitors

AMGEN INC0 citations50
US7709501B2May 4, 2010

Vanilloid receptor ligands and their use in treatments

AMGEN INC0 citations41

HITACHI LTD

5 patents

BO YUNXIN Y

2 patents

BROWN JAMES

1 patent

NORMAN MARK H

1 patent

ASHTON KATE

1 patent